NCT05102240Recruiting
Development of Clinically High Efficient Platforms for Individualised Treatment of Cervix Cancer
Developing Clinical High Efficiency Platforms for Individualised Treatment Through Integration of Advanced Radiation Technology, Quantitative Imaging and Molecular Biology and Machine Learning for Treatment of Cervix Cancer.
Source: ClinicalTrials.gov · Last updated 20 Feb 2026
Brief summary (registry, in English)
Retrospective study utilizing patient data to develop and validate Machine Learning application. Available imaging data sets of patients who have completed treatment will be used to develop Normal tissue complication probability and Tumour control probability Hypothesis Integrating existing radiation treatment information, quantitative imaging and patient outcome data from completed and ongoing clinical trials will allow development of knowledge based systems for efficient treatment delivery and allow selection of patients for intensified treatment approaches in cervix cancer.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 1800 (estimated)
- First submitted
- 20 Oct 2021
- Start date
- 24 Feb 2022
- Primary completion date
- 30 Jun 2026
- Lead sponsor
- Tata Memorial Hospital
- Diseases
- Cervical cancer
- NCT number
- NCT05102240
What you commit to
- Study type: Observational
- Planned participants: 1800
- From 24 Feb 2022 to the primary completion date, 30 Jun 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Lack of disease or toxicity outcomes.
Other
- Lack of images in the hospital database.
Who the study is looking for
- For Aim 1 and Aim 3:
- Patients treated within ongoing and completed clinical trials of chemoradiation and brachytherapy for cervix cancer with access to MRI/CT images at the time of diagnosis and brachytherapy For Aim 2
- Patients undergoing postoperative or definitive radiotherapy and treated within trials of postoperative or definitive RT.
Age in the registry: 18 years to 90 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Advanced Centre of Treatment Research and Education In Cancer,Tata Memorial Centre Coordinator of this site? Confirm its status | Navi Mumbai | India | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.